Overview

Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Patients With Spinal Cord Injury, Polytrauma and Burn Injury

Status:
Recruiting

Trial end date:
2022-06-20

Target enrollment:

Participant gender:

Summary

The use of conditioning open-label placebo (COLP) will be studied as a dose extension method to lower opioid dosage in patients with spinal cord injury, polytrauma, and burn injury. The goal is to provide the same level of pain relief with a reduced opioid dose to diminish adverse effects as well as the risk of addiction associated with narcotic treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Spaulding Rehabilitation Hospital

Treatments:

Oxycodone